India Glycols opened higher at ₹323.00, compared with its previous close of ₹319.80. During today's session, the stock has traded between ₹310.75 and ₹364.00, with an average traded price of ₹353.38. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in India Glycols is now worth
₹ 7,551.00
resulting in a loss of
₹ 2,449.00 (24.49%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+32.60 (+10.19%)
Day High
₹364.00
Day Low
₹310.75
Day Open
₹323.00
Prev Close
₹319.80
Volume
1,71,35,803
Value Traded
₹605.55 Cr
1W Return
16.17%
1M Return
19.50%
3M Return
-67.00%
6M Return
-61.95%
1Y Return
-62.40%
Market Cap (₹ Cr.)
2,362
PE Ratio
6.80
PB Ratio
0.73
Dividend Yield
2.35%
ROE
9.98%
ROCE
12.07%
Book Value (₹)
437.55
Face Value (₹)
5.00
EPS (TTM)
14.45
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
16.17%
6 Week
-
1 Month
19.50%
3 Month
-67.00%
9 Month
-63.43%
India Glycols receives ₹6.22 lakh penalty from Uttarakhand tax officer
India Glycols received a penalty of ₹6,22,080 from Uttarakhand State Tax Officer. Violation involved missing e-way bill Part-B details for one of three invoices. Company deposited penalty to release vehicle and plans to appeal the order. Inspection occurred at Singhniwala with no discrepancy in goods quantity or description.
2 days agoIndia Glycols outlines cost apportionment for demerged entities
India Glycols issued guidance on apportioning cost of acquisition post-demerger. Original cost is split 31.77% to India Glycols, 20.61% to Ennature Bio Pharma, and 47.62% to IGL Spirits. Scheme became effective September 1, 2026, with record date September 2, 2026. Allotment ratio was 1:3 for Ennature Bio Pharma and 1:1 for IGL Spirits relative to India Glycols shares.
7 days agoIndia Glycols shifts analyst meetings on Oct 7-8 to virtual mode
India Glycols changed meeting mode to virtual for Oct 7-8. Update supersedes original in-person plan announced Oct 1. All other event details remain unchanged per company filing.
7 days agoIndia Glycols to host investor meetings in Singapore on Sep 28-29
India Glycols Limited will hold analyst meetings in Singapore on September 28-29, 2026. Events include a non-deal meeting and a roadshow. Discussions limited to publicly available information with no UPSI intended. Disclosure made under Regulation 30 of SEBI Listing Regulations.
21 days agoIndia Glycols hosts plant visit for investors on Sep 19-20
India Glycols hosts plant visits for investors on September 19 and 20, 2026. Tours cover manufacturing facilities in Kashipur and Dehradun. Discussions limited to publicly available information per SEBI norms. Ankur Jain, Company Secretary, issued the disclosure on September 16.
27 days agoEnnature Bio Pharma allots shares, appoints CFO in merger update
Ennature Bio Pharma allotted 2.23 crore shares to India Glycols shareholders at a 1:3 ratio. Ajay Sharma appointed as CFO; Preeti Choudhary named Company Secretary. Mukesh Agarwal & Co. appointed as Secretarial Auditor for five years. Three non-executive directors resigned earlier in September citing personal reasons.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,371.10 | +1.59% | ₹99,727.08 | 52.10 | +2.55% | |
| ₹4,540.00 | -0.33% | ₹60,828.01 | 86.55 | +51.92% | |
| ₹1,199.80 | +3.00% | ₹31,723.33 | 77.84 | -32.63% | |
| ₹718.45 | +1.82% | ₹20,095.78 | 93.88 | +31.81% | |
| ₹541.35 | -0.55% | ₹13,419.95 | -375.24 | +19.44% | |
| ₹798.10 | +2.41% | ₹2,510.93 | 24.57 | -28.84% | |
| ₹869.55 | -0.95% | ₹1,986.65 | 11.59 | -2.78% | |
| ₹72.46 | +1.00% | ₹1,412.89 | -49.53 | -42.55% | |
| ₹579.15 | -1.22% | ₹1,162.89 | 14.25 | -43.01% | |
| ₹132.56 | -0.31% | ₹1,119.43 | 45.38 | -48.61% | |
| ₹874.10 | +1.17% | ₹818.78 | 13.43 | -10.14% | |
| ₹6.33 | -2.16% | ₹202.52 | -64.40 | -15.03% |
An investment of ₹10,000 made 5 years ago in India Glycols is now worth
₹ 7,551.00
resulting in a loss of
₹ 2,449.00 (24.49%)
Note: Past profits do not guarantee future returns.
